Chugai, BioMarin deal

Chugai granted BioMarin U.S. and Japanese rights to Chugai’s C-type natriuretic peptide ( CNP; NPPC) patent, which covers BioMarin’s achondroplasia candidate vosoritide. The analog of CNP is in Pha...